SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-022819
Filing Date
2020-11-05
Accepted
2020-11-05 17:12:53
Documents
52
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20200930_10q.htm 10-Q 695704
2 EXHIBIT 31.1 ex_210637.htm EX-31.1 13376
3 EXHIBIT 31.2 ex_210638.htm EX-31.2 12997
4 EXHIBIT 32.1 ex_210639.htm EX-32.1 4508
5 EXHIBIT 32.2 ex_210640.htm EX-32.2 4315
  Complete submission text file 0001437749-20-022819.txt   3286319

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT govx-20200930.xml EX-101.INS 438552
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20200930.xsd EX-101.SCH 40779
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20200930_cal.xml EX-101.CAL 24770
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20200930_def.xml EX-101.DEF 284847
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20200930_lab.xml EX-101.LAB 222988
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20200930_pre.xml EX-101.PRE 303187
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 201291537
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences